In the rapidly evolving landscape of healthcare, genetic testing is emerging as a pivotal force, promising to transform patient care through precision medicine. The insights derived from our genetic codes hold the potential to not only prevent diseases but also optimize treatments and promote healthier living. Yet, as highlighted in a recent MedCity News article, the journey towards realizing this potential is fraught with challenges, particularly around patient privacy and data sharing.
The Role of Information Technology
A critical component in addressing these challenges is information technology security. Organizations are turning to certifications like HITRUST to establish standards for safeguarding sensitive information. By aligning with these standards, they can protect data while facilitating the sharing necessary to enhance medical knowledge and patient care.
Collaborative Efforts and Data Sharing
Collaboration is at the heart of advancing genetic testing. Companies are contributing de-identified variant data to public health databases such as ClinVAR and the SEER Cancer Registries. These efforts, supported by cancer research registries, deepen insights and expedite advancements in patient care.
The analysis of expansive data sets is crucial for understanding diseases, allowing researchers to access, assess, and test hypotheses. This collaborative approach is paving the way for tailored treatment plans and new biological discoveries, enhancing early disease detection and intervention.
Integration with Electronic Health Records
Integrating genetic testing with Electronic Health Records (EHR) is another key strategy for improving patient outcomes. Collaborations with EHR vendors like Epic, Flatiron, and Athena streamline processes, making it easier for providers to order genetic products, optimize screening protocols, and identify potential pharmacogenetic interactions. Such collaborations break down silos, enhancing data exchange for more effective research and patient care.
Challenges and Future Trends
Despite the promising progress, the integration of genetic testing into mainstream medicine presents challenges, including managing the vast volume of genomic data. Companies are focusing on presenting complex clinical interpretations, integrating common data ontologies, overcoming data fragmentation, and ensuring data privacy to address these hurdles.
Looking ahead, the industry anticipates significant advancements, with trends like developing tests for early cancer recurrence detection and embracing a multi-omics approach that integrates RNA, proteins, and AI insights. The integration of generative AI for documentation and genetic counseling is another notable development on the horizon.
A New Era in Healthcare
Genetic testing represents more than just a scientific advancement; it signifies a fundamental shift in how we approach health and wellness. As public understanding grows and technology advances, we find ourselves at the dawn of a new era in healthcare, where our genetic code becomes a roadmap to better health and longevity.
About the Author
Kevin Haas, Ph.D., serves as the Chief Technology Officer at Myriad Genetics, where he leads the development of the precision medicine platform. With expertise in molecular simulation and machine learning, Haas is advancing genomics and digital patient/provider experiences. He has co-authored 16 peer-reviewed publications and nine patent applications, bringing a wealth of experience to his role.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
A Leon County judge has ordered Florida’s administrative courts to restart arbitration on more than 400 stalled Citizens Insurance cases, reigniting a legal showdown over whether the state’s insurer of last resort can force policyholders out of traditional courtrooms. The ruling directly conflicts with a separate Hillsborough County injunction that called Citizens’ arbitration system “likely unconstitutional,” setting up a rare judicial clash that could reshape how Floridians fight denied or underpaid property claims.
Inhabit has launched a powerful new suite of AI‑driven tools designed to modernize leasing, strengthen fraud prevention, and simplify compliance for property managers nationwide. From advanced leasing assistants and NYC‑specific regulatory AI to instant income verification and upcoming identity‑screening tech, these innovations aim to solve some of the industry’s toughest challenges. Real estate professionals—especially in multifamily—can expect faster operations, stronger safeguards, and a more efficient workflow as these technologies roll out.
A growing body of demographic research suggests that today’s housing shortage may give way to a future surplus as millions of Baby Boomer–owned homes return to the market over the next two decades. With affordability at historic lows and inventory still tight, this long‑term shift could eventually cool prices and transform the landscape for real estate professionals. The analysis draws parallels to aging populations abroad and highlights why understanding demographic cycles is becoming essential knowledge for agents, brokers, and mortgage professionals preparing for the next era of the housing market.
Griffin Funding has appointed John Jones as Senior Vice President of Growth and EOS Integrator, a move aimed at accelerating the lender’s push toward $3 billion in annual non‑QM loan volume by 2030. Jones, previously the company’s fractional integrator and COO, will lead expansion strategies, operational optimization, and leadership development as the lender strengthens its position in the increasingly competitive non‑QM market.
A new report shows Tampa outperforming the national real estate slowdown with a 6.5 percent annualized multifamily return, nearly 20 percent higher than the U.S. average. While many metros face oversupply or regulatory drag, Tampa’s balanced development pipeline, strong population growth, and investor confidence continue to fuel resilient performance heading into 2026.
A new Colliers outlook reveals that global capital is picking up momentum again, with investors shifting toward more active, hands‑on strategies. Data centers are surging, offices are rebounding, and value‑add plays like adaptive reuse are defining the next wave of opportunity. Regional markets—from the U.S. to APAC—are seeing renewed demand as fundraising spreads across continents and investors seek speed, control, and scale. This snapshot helps today’s real estate and finance professionals stay aligned with where global money is moving next.
